Iterum Therapeutics plc Annual Nonoperating Income (Expense) in USD from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Iterum Therapeutics plc quarterly/annual Nonoperating Income (Expense) history and growth rate from 2016 to 2024.
  • Iterum Therapeutics plc Nonoperating Income (Expense) for the quarter ending December 31, 2024 was -$2.89M, a 266% decline year-over-year.
  • Iterum Therapeutics plc Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was -$5.84M, a 160% decline year-over-year.
  • Iterum Therapeutics plc annual Nonoperating Income (Expense) for 2024 was -$5.84M, a 160% decline from 2023.
  • Iterum Therapeutics plc annual Nonoperating Income (Expense) for 2023 was $9.71M.
  • Iterum Therapeutics plc annual Nonoperating Income (Expense) for 2022 was -$13.8M, a 79.3% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$5.84M -$15.5M -160% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-07
2023 $9.71M +$23.5M Jan 1, 2023 Dec 31, 2023 10-K 2025-02-07
2022 -$13.8M +$52.6M +79.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-07
2021 -$66.3M -$47.2M -247% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-28
2020 -$19.1M -$18.5M -2778% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$665K -$640K -2560% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-28
2018 -$25K -$518K -105% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-12
2017 $493K +$485K +6063% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $8K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.